0001562180-16-002855.txt : 20160729
0001562180-16-002855.hdr.sgml : 20160729
20160729162319
ACCESSION NUMBER: 0001562180-16-002855
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20160728
FILED AS OF DATE: 20160729
DATE AS OF CHANGE: 20160729
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ARRAY BIOPHARMA INC
CENTRAL INDEX KEY: 0001100412
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 841460811
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0630
BUSINESS ADDRESS:
STREET 1: 3200 WALNUT STREET
CITY: BOULDER
STATE: CO
ZIP: 80301
BUSINESS PHONE: 3033816600
MAIL ADDRESS:
STREET 1: 3200 WALNUT STREET
CITY: BOULDER
STATE: CO
ZIP: 80301
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Haddock Jason
CENTRAL INDEX KEY: 0001680628
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-16633
FILM NUMBER: 161794380
MAIL ADDRESS:
STREET 1: C/O ARRAY BIOPHARMA INC., 3200 WALNUT ST
CITY: BOULDER
STATE: CO
ZIP: 80301
3
1
primarydocument.xml
PRIMARY DOCUMENT
X0206
3
2016-07-28
0
0001100412
ARRAY BIOPHARMA INC
ARRY
0001680628
Haddock Jason
C/O ARRAY BIOPHARMA, 3200 WALNUT ST
BOULDER
CO
80301
false
true
false
false
CFO
Stock Option (Right to Buy)
3.77
2026-07-28
Common Stock
575000.00
D
The option vests in four equal annual installments beginning July 28, 2017.
John R. Moore, attorney in fact for Reporting Person
2016-07-29
EX-24
2
array_poa-haddock.txt
JASON HADDOCK POA
POWER OF ATTORNEY
The undersigned constitutes and appoints John R.
Moore as his true and lawful attorney-in-fact and agent,
with full power of substitution and resubstitution, from the undersigned
and in the undersigned's name, place and stead, in any and all capacities,
to execute and file on the undersigned's behalf all Forms 3, 4 and 5
(including any amendments thereto) that the undersigned may be required
to file with the U.S. Securities and Exchange Commission as a result of the
undersigned's ownership of or transactions in securities of Array BioPharma
Inc. The authority of John R. Moore under this
statement shall continue until the undersigned is no longer required to
file Forms 3, 4 and 5 with regard to the undersigned's ownership of or
transactions in securities of Array BioPharma Inc., unless earlier revoked
in writing. The undersigned acknowledges that John R. Moore is not assuming
any of the undersigned's responsibilities
to comply with Section 16 of the Securities Exchange Act of 1934.
Signature Date
Jason Haddock
July 18, 2016